Article thumbnail

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates

By Keith Limbach, Joao Aguiar, Kalpana Gowda, Noelle Patterson, Esteban Abot, Martha Sedegah, John Sacci and Thomas Richie
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium Limbach et al.
  2. (2009). A: A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults. Vaccine
  3. (2010). A: Protection from malaria sporozoite challenge correlates with frequency of TRAP-specific CD8+ T cells secreting IFN╬│ [abstract]. Malaria: New Approaches to Understanding Host-Parasite Interactions
  4. (2002). Alpers M: A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis
  5. (1997). Compact, synthetic, vaccinia virus early/ late promoter for protein expression. Biotechniques
  6. (2002). D: A proteomic view of the Plasmodium falciparum life cycle. Nature
  7. (2004). D: High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res
  8. (2009). Discovering novel pre-erythrocytic antigens for malaria [abstract]. Am J Trop Med Hyg
  9. (2009). Doumbo O: Allele-specific efficacy of an AMA-1-based malaria subunit vaccine [abstract]. Am J Trop Med Hyg
  10. (1989). E: Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.
  11. (1987). E: Vaccinia virus as an expression vector. Methods Enzymol
  12. (1990). Felgner P: Direct gene transfer into mouse muscle in vivo. Science
  13. (2009). for the MSP-1 Malaria Vaccine Working Group: Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One
  14. (2010). Genetically engineered, attenuated wholecell vaccine approaches for malaria. Hum Vaccines
  15. (2010). Heussler V: Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes. PLoS Pathog
  16. (2000). Hoffman S: Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigenexpressing recombinant poxvirus.
  17. (1996). Hoffman SL: Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
  18. (2003). HP: etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface. Mol Biol Cell
  19. (2006). Kneteman N: Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers.
  20. (2009). Malaria Report
  21. (2008). Peng X: Assessment and improvement of the Plasmodium yoelii yoelii genome annotation through comparative analysis. Bioinformatics
  22. (2007). Protracted sterile protection with Plasmodium yoelii preerythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis
  23. (1987). RL: Characterization of Plasmodium yoelii monoclonal antibodies directed against stagespecific sporozoite antigens. Infect Immun
  24. (2006). Rosenthal PJ: Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion. PLoS Pathog
  25. (2004). S: Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun
  26. (2002). S: Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage.
  27. (2008). S: Interaction of an atypical Plasmodium falciparum ETRAMP with human apolipoproteins.
  28. (2007). S: L-FABP is a critical host factor for successful malaria liver stage development.
  29. (2004). SH: Differential transcriptome profiling identifies Plasmodium genes encoding preerythrocytic stage-specific proteins. Mol Microbiol
  30. (2009). Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int
  31. (2002). T: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.
  32. (2007). T: Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. PLoS One
  33. (2009). The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunol
  34. (2010). The wheat germ cellfree protein synthesis system: A key tool for novel malaria vaccine candidate discovery. Acta Trop
  35. (2005). Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol Biochem Parasitol
  36. (2004). W: Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther
  37. (2003). Winzeler : Discovery of gene function by expression profiling of the malaria parasite life cycle. Science